SCHEDULE 13D

Company

Immunocore Holdings plc

Filed

July 21, 2022

Accession Number

0000950142-22-002280

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →